Anthony P. Zook, CEO of NeoGenomics Inc. ($NEO), bought company shares on the open market twice in the last year, for a total of about $249,000. His latest purchase occurred on August 6, 2025. Among nearly 5,000 insiders, his buying ranks 1,366th by dollar amount, well below the average of $1.5 million over about 3.3 transactions. Zook reported no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | M | Restricted Stock Unit | 140498 | $0.00 | 687,916.0000 | 129,812,211 | 16.96% | 0.11% |
| April 1, 2026 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | F | Common Stock | 45453 | $0.00 | 152,011.0000 | 129,812,211 | 23.02% | 0.04% |
| April 1, 2026 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | M | Common Stock | 140498 | $0.00 | 197,464.0000 | 129,812,211 | 246.63% | 0.11% |
| March 1, 2026 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | A | Stock Option (Right to Buy) | 675676 | $0.00 | 1,422,628.0000 | 129,812,211 | 90.46% | 0.52% |
| March 1, 2026 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | A | Restricted Stock Unit | 406918 | $0.00 | 828,414.0000 | 129,812,211 | 96.54% | 0.31% |
| Aug. 6, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | P | Common Stock | 17900 | $5.58 | 56,966.0000 | 128,461,383 | 45.82% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | M | Common Stock | 12254 | $0.00 | 42,490.0000 | 128,461,383 | 40.53% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | F | Common Stock | 3424 | $0.00 | 39,066.0000 | 128,461,383 | 8.06% | 0.00% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | M | Restricted Stock Unit | 12254 | $0.00 | 421,496.0000 | 128,461,383 | 2.83% | 0.01% |
| May 6, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | P | Common Stock | 18900 | $7.88 | 30,236.0000 | 128,461,383 | 166.73% | 0.01% |
| April 1, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | A | Stock Option (Right to Buy) | 729927 | $0.00 | 746,952.0000 | 128,461,383 | 4287.38% | 0.57% |
| April 1, 2025 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Chief Executive Officer | A | Restricted Stock Unit | 421496 | $0.00 | 433,750.0000 | 128,461,383 | 3439.66% | 0.33% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Director | M | Restricted Stock Unit | 11336 | $0.00 | 12,254.0000 | 0 | 48.05% | 0.00% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Director | M | Common Stock | 11336 | $0.00 | 11,336.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Director | A | Restricted Stock Unit | 12254 | $0.00 | 23,590.0000 | 0 | 108.10% | 0.00% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | Zook Anthony P. | Director | A | Stock Option (Right to Buy) | 8672 | $0.00 | 17,025.0000 | 0 | 103.82% | 0.00% |